| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3289444 | Gastroenterología y Hepatología | 2006 | 5 Pages |
Abstract
Several studies on biological therapy suggest that certolizumab, adalimumab and visilizumab, among other new drugs, could be useful in the treatment of Crohn's disease.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Miquel Sans,